Intensity Therapeutics, Inc. - Common Stock

INTS49

Penny Stock

$2.73arrow_drop_up0.37%$0.00

Penny Stock

INTS49

$2.73

arrow_drop_up0.37%$0.00

Penny Stock

Performance History

Key Stats
Open	$2.74
Prev. Close	$2.70
EPS	-1.07
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$35.77M
PE Ratio	-

	LOW	HIGH
Day Range	2.59	2.82
52 Week Range	2.01	11.44

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.07

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Intensity Therapeutics, Inc. - Common Stock (INTS)

Intensity Therapeutics, Inc. (INTS) is a biotechnology company that focuses on developing and commercializing novel cancer therapies. The company's lead product candidate, INT230-6, is a drug designed to kill cancer cells while sparing healthy cells. INT230-6 is based on a proprietary technology called DfuseRx, which employs low electrical current to facilitate the entry of drugs into cancer cells.

INT230-6 has shown promising results in preclinical studies, demonstrating potent anti-tumor activity across a wide range of cancer types. The drug has also been well-tolerated in animal models and has shown to enhance the efficacy of other cancer treatments, such as chemotherapy and immunotherapy.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.
Headquarters: Westport
Employees: 0
Exchange: NASDAQ

add Intensity Therapeutics, Inc. - Common Stock to watchlist

Keep an eye on Intensity Therapeutics, Inc. - Common Stock

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Intensity Therapeutics, Inc. - Common Stock's (INTS) price per share?

The current price per share for Intensity Therapeutics, Inc. - Common Stock (INTS) is $2.74. The stock has seen a price change of $0.01 recently, indicating a 0.37% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Intensity Therapeutics, Inc. - Common Stock (INTS)?

For Intensity Therapeutics, Inc. - Common Stock (INTS), the 52-week high is $11.44, which is 317.67% from the current price. The 52-week low is $2.01, the current price is 36.27% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Intensity Therapeutics, Inc. - Common Stock (INTS) a growth stock?

Intensity Therapeutics, Inc. - Common Stock (INTS) has shown an average price growth of -4.13% over the past three years. It has received a score of 72 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Intensity Therapeutics, Inc. - Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Intensity Therapeutics, Inc. - Common Stock (INTS) stock price performance year to date (YTD)?

As of the latest data, Intensity Therapeutics, Inc. - Common Stock (INTS) has a year-to-date price change of -68.41%. Over the past month, the stock has experienced a price change of -16.96%. Over the last three months, the change has been -36.3%. Over the past six months, the figure is -45.98%.

help

Is Intensity Therapeutics, Inc. - Common Stock (INTS) a profitable company?

Intensity Therapeutics, Inc. - Common Stock (INTS) has a net income of -$10.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.32M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Intensity Therapeutics, Inc. - Common Stock (INTS)?

Intensity Therapeutics, Inc. - Common Stock (INTS) has a market capitalization of $35.78M. The average daily trading volume is 2.71, indicating the stock's liquidity and investor engagement.